(1.26%) 5 127.93 points
(1.21%) 38 688 points
(1.97%) 16 154 points
(-0.77%) $78.34
(5.45%) $2.15
(0.00%) $2 309.50
(-0.45%) $26.71
(0.37%) $966.20
(-0.36%) $0.929
(-1.20%) $10.86
(-0.11%) $0.797
(0.37%) $91.47
Live Chart Being Loaded With Signals
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments...
Stats | |
---|---|
本日の出来高 | 227 455 |
平均出来高 | 559 147 |
時価総額 | 1.00B |
EPS | £0 ( 2024-02-28 ) |
Last Dividend | £0.500 ( 2023-05-25 ) |
Next Dividend | £0 ( N/A ) |
P/E | 35.43 |
ATR14 | £0.161 (0.06%) |
ボリューム 相関
Spire Healthcare Group 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Spire Healthcare Group 相関 - 通貨/商品
Spire Healthcare Group 財務諸表
Annual | 2023 |
収益: | £1.36B |
総利益: | £520.60M (38.31 %) |
EPS: | £0.0676 |
FY | 2023 |
収益: | £1.36B |
総利益: | £520.60M (38.31 %) |
EPS: | £0.0676 |
FY | 2022 |
収益: | £1.20B |
総利益: | £440.50M (36.75 %) |
EPS: | £0.0214 |
FY | 2021 |
収益: | £1.11B |
総利益: | £491.20M (44.40 %) |
EPS: | £-0.0240 |
Financial Reports:
No articles found.
Spire Healthcare Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0.500 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.800 | 2015-06-04 |
Last Dividend | £0.500 | 2023-05-25 |
Next Dividend | £0 | N/A |
Payout Date | 2023-06-23 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | £21.20 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 2.58 | -- |
Div. Sustainability Score | 8.47 | |
Div.Growth Potential Score | 4.15 | |
Div. Directional Score | 6.31 | -- |
Year | Amount | Yield |
---|---|---|
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £3.80 | 1.64% |
2019 | £3.80 | 3.44% |
2020 | £2.50 | 1.76% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0.500 | 0.22% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OCN.L | Dividend Knight | 2023-05-18 | Annually | 19 | 3.96% | |
ESNT.L | Dividend King | 2023-09-21 | Semi-Annually | 20 | 4.44% | |
STAN.L | Dividend Junior | 2023-08-10 | Annually | 32 | 1.92% | |
JMAT.L | Dividend Knight | 2023-06-08 | Semi-Annually | 33 | 1.93% | |
CAPD.L | Dividend King | 2023-08-31 | Semi-Annually | 10 | 2.58% | |
PSHD.L | No Dividend Player | 2023-08-17 | Annually | 6 | 0.41% | |
GCP.L | Dividend King | 2023-08-10 | Quarterly | 15 | 3.86% | |
AJB.L | Dividend Knight | 2023-06-08 | Semi-Annually | 6 | 1.30% | |
TMIP.L | Dividend Junior | 2023-08-10 | Quarterly | 2 | 0.02% | |
LTHM.L | Dividend Knight | 2023-08-03 | Semi-Annually | 33 | 0.87% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0201 | 1.500 | 9.60 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0119 | 1.200 | 9.60 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0372 | 1.500 | -0.698 | -1.047 | [0.1 - 1] |
payoutRatioTTM | 0.0733 | -1.000 | 9.27 | -9.27 | [0 - 1] |
currentRatioTTM | 0.691 | 0.800 | -1.544 | -1.236 | [1 - 3] |
quickRatioTTM | 0.483 | 0.800 | -1.867 | -1.493 | [0.8 - 2.5] |
cashRatioTTM | 0.156 | 1.500 | -0.243 | -0.365 | [0.2 - 2] |
debtRatioTTM | 0.203 | -1.500 | 6.62 | -9.93 | [0 - 0.6] |
interestCoverageTTM | 1.360 | 1.000 | -0.607 | -0.607 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.495 | 2.00 | 9.83 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.286 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.627 | -1.500 | 7.49 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.383 | 1.000 | 6.95 | 6.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0931 | 1.000 | -0.138 | -0.138 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.431 | 1.000 | 8.72 | 8.72 | [0.2 - 2] |
assetTurnoverTTM | 0.594 | 0.800 | 9.37 | 7.50 | [0.5 - 2] |
Total Score | 8.47 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.29 | 1.000 | 6.44 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0372 | 2.50 | -0.449 | -1.047 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.286 | 2.00 | 9.90 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.204 | 1.500 | 4.91 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.495 | 2.00 | 9.83 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0733 | 1.500 | 9.27 | -9.27 | [0 - 1] |
pegRatioTTM | -38.04 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.147 | 1.000 | 8.82 | 0 | [0.1 - 0.5] |
Total Score | 4.15 |
Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。